Ford, General Motors and Stellantis are escalating their dispute over the revised North American trade pact, filing a formal complaint with the White House over provisions they say could cost the group billions of dollars.
Ford, General Motors and Stellantis are escalating their dispute over the revised North American trade pact, filing a formal complaint with the White House over provisions they say could cost the group billions of dollars.

Ford, General Motors and Stellantis are taking their USMCA fight to the White House, arguing that revised trade-pact provisions could cost the Detroit Three billions of dollars in annual losses.
The complaint targets the USMCA's tightened rules of origin and labor-content thresholds, which the automakers argue would raise assembly costs and undercut the competitiveness of their North American plants, according to the filing.
The 2020 agreement that replaced NAFTA requires 75 percent regional value content for passenger vehicles and mandates that 40 percent of a vehicle's value come from plants paying at least $16 an hour. The automakers contend the revised thresholds, layered on top of shifting trade policy, impose costs that ripple across their supplier networks.
For the Detroit Three, the stakes are measured in billions of dollars of potential annual losses — a hit that would squeeze already-thin margins and likely push up vehicle prices for consumers across North America. The complaint sets up a confrontation with the White House as the industry weighs how to restructure sourcing and production.
The USMCA's regional value content requirement, which climbed from 62.5 percent under NAFTA to 75 percent, forces automakers to source a larger share of components within North America. The high-wage provision adds another constraint, requiring that 40 percent of a vehicle's value be produced in plants paying at least $16 an hour. For the Detroit Three, whose supply chains stretch across the United States, Canada and Mexico, meeting those thresholds while absorbing higher labor and materials costs narrows the margin for error on every vehicle sold.
The complaint lands as the industry already faces pressure from elevated vehicle pricing and financing costs that have softened demand across the region. Ford, General Motors and Stellantis together account for a large share of North American light-vehicle production, and any cost increase would be felt across their dealer networks and by the parts suppliers that feed their assembly lines.
The last major renegotiation of the pact, completed in 2018 and in force since July 2020, was itself shaped by automaker concerns about the previous NAFTA framework. The current dispute marks the first time the Detroit Three have formally challenged the revised terms before the administration, a step that could test how far the White House is willing to accommodate the industry.
If the automakers' challenge fails to win relief, the added costs would most likely be passed through to consumers, compounding affordability pressures that have already slowed new-vehicle sales. Rivals including Toyota and Honda, which also assemble vehicles in North America, would face similar exposure, potentially reshaping competitive dynamics across the market.
The bearish read on the dispute has weighed on the sector, with investors watching whether the cost pressure translates into weaker earnings guidance from the automakers. A prolonged fight would also complicate planning for suppliers that have already invested in shifting production to meet the agreement's content rules.
The complaint also sets a precedent for how the industry engages the White House on trade policy. A favorable resolution could ease the cost burden and protect margins; an unfavorable one would force deeper restructuring of sourcing and production footprints. With the dispute now before the administration, the outcome will help determine whether the Detroit Three can hold their ground on cost and pricing through the next cycle.
This article is for informational purposes only and does not constitute investment advice.